View Older Stories View More Recent Stories
-
Ballard Power (BLDP) Gets 'Nice' Win with Chinese HD7 Module Order; Roth Capital Comments
-
Biodel (BIOD) Prices 32.6M Common Share Offering at $0.92/Share
-
Biodel Announces Pricing of Public Offering of Common Stock
-
Roth Capital Starts Galmed Pharmaceuticals (GLMD) at Buy, PT $20
-
Roth Capital Starts Eco-Stim Energy (ESES) at Buy
-
LightBeam Electric (LEC) Files $100M IPO
-
Over-Enrollment in Galena's (GALE) Phase III PRESENT Should Strengthen Validity of Results - Roth Capital
-
Notable Analyst Rating Changes 4/14: (PAY) (AEZS) (MDR) Upgraded; (AMTD) (SANM) (WWWW) Downgraded
-
Roth Capital Starts uniQure BV (QURE) at Buy
-
Roth 'Encouraged' by Cytori Therapeutics' (CYTX) Scleradec-I Study; Sees Mid-2015 Start for STAR Study
-
Roth Capital Starts Calgon Carbon Corp. (CCC) at Buy
-
Galena Biopharma Announces Closing of Over-Allotment Option, Increasing Total Gross Proceeds to $43.7 Million
-
Roth Capital Downgrades ANI Pharmaceuticals (ANIP) to Neutral
-
BioBlast Pharma's (ORPN) Cabaletta Fast Track Designation Viewed as Incremental Positive by Roth Capital; 'Buy' Rating Affirmed
-
Conatus Announces Completion of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Conatus Announces Completion of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Notable 52-Week Highs and Lows 4/8: (ADXS) (LULU) (DG) High; (SPPI) (CEQP) Low
-
Door Now Open for Sandoz's Generic Version of Spectrum Pharma's (SPPI) Fusilev; Roth Affirms at 'Neutral'
-
Notable Analyst Rating Changes 4/8: (XRX) (LULU) (HOLI) Upgraded; (WBMD) (AAPL) (NLY) Downgraded
-
Roth Capital Starts Energous Corp (WATT) at Buy
-
Streetinsider.com's Hot Lunchtime Reads 4/6: (RAD) (ALTR) (EMN) (NOW) (CYTX)
-
Synta Pharmaceuticals Closes Public Offering of Common Stock
-
Celution System Clearance in China is 'Major Win' for Cytori (CYTX) - Roth Capital
-
Conatus Pharmaceuticals (CNAT) Prices 3.5M Common Offering at $5.75/Share
-
Conatus Announces Pricing of Public Offering of Common Stock
-
Conatus Announces Pricing of Public Offering of Common Stock
-
Conatus Pharmaceuticals (CNAT) Falls on Plans to Offer Common Stock
-
Conatus Announces Proposed Public Offering of Common Stock
-
Conatus Announces Proposed Public Offering of Common Stock
-
Multiple Positives Appear from Latest Publication of Lion Biotech's (LBIO) TIL Data - Roth
-
Roth Remains Positive on Concert Pharma (CNCE) Following Equity Offering; Affirms 'Buy' Rating
-
Roth Places RGS Energy (RGSE) 'Under Review' Ahead of Q4, FY14 Report
-
Synta Pharma (SNTA) Prices 22M Common Offering at $1.75/Share
-
RMG Networks Reports Fourth Quarter and Year End 2014 Results
-
Roth Capital Downgrades Hyperion Therapeutics (HPTX) to Neutral
-
UPDATE: Can-Fite BioPharma's (CANF) CF101 Phase 2/3 Missed Primary Endpoint; Roth Downgrades to Neutral
-
Streetinsider.com's Hot Lunchtime Reads 3/30: (MGA) (YELP) (AAPL) (BBRY)
-
Lion Biotechnologies (LBIO) Receives First External Validation of Phase I TIL/Yervoy in Metastatic Melanoma; Roth Capital Affirms at 'Buy'
-
Roth Affirms Ligand (LGND) at 'Buy' Following Amgen (AMGN), Spectrum (SPPI) Updates
-
Roth Capital Downgrades Superior Drilling Products (SDPI) to Neutral
-
Roth Capital Downgrades FutureFuel Corp. (FF) to Neutral
-
SolarEdge Technologies (SEDG) IPO Opens Up 11%
-
ROTH Capital Partners Expands Banking Practice with the Addition of David T. Farina, CFA as a Managing Director, Investment Banking
-
Roth Comments on Galena's (GALE) Expanded NeuVax, Trastuzumab Enrollments; Affirms 'Buy' Rating
-
SolarEdge Technologies, Inc. Announces Pricing of Its Initial Public Offering
-
Low ASPs, Higher Operating Expenses Push Yingli Green Energy (YGE) to Wider-than-Expected Q4 Loss - Roth
-
Roth Capital Starts Argos Therapeutics (ARGS) at Buy
-
BioLineRx's (BLRX) BL-8040 Better Positioned as SOC Alternate in SC Mobilization - Roth Capital
-
RMG Networks (RMGN) Announces $25M Conv. Preferred Offering
-
RMG Networks Raises $25 Million in Private Placement of Convertible Preferred Stock

